Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

908 Devices Inc.

MASSNASDAQ
Healthcare
Medical - Devices
$6.99
$0.32(4.80%)
U.S. Market opens in 14h 26m

908 Devices Inc. Fundamental Analysis

908 Devices Inc. (MASS) shows moderate financial fundamentals with a PE ratio of -56.72, profit margin of -7.17%, and ROE of -2.96%. The company generates $0.1B in annual revenue with strong year-over-year growth of 18.72%.

Key Strengths

Cash Position47.83%
PEG Ratio-0.73
Current Ratio3.49

Areas of Concern

ROE-2.96%
Operating Margin-1.09%
We analyze MASS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 38.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
38.9/100

We analyze MASS's fundamental strength across five key dimensions:

Efficiency Score

Weak

MASS struggles to generate sufficient returns from assets.

ROA > 10%
-2.16%

Valuation Score

Excellent

MASS trades at attractive valuation levels.

PE < 25
-56.72
PEG Ratio < 2
-0.73

Growth Score

Moderate

MASS shows steady but slowing expansion.

Revenue Growth > 5%
18.72%
EPS Growth > 10%
-87.61%

Financial Health Score

Excellent

MASS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
3.49

Profitability Score

Weak

MASS struggles to sustain strong margins.

ROE > 15%
-295.53%
Net Margin ≥ 15%
-7.17%
Positive Free Cash Flow
No

Key Financial Metrics

Is MASS Expensive or Cheap?

P/E Ratio

MASS trades at -56.72 times earnings. This suggests potential undervaluation.

-56.72

PEG Ratio

When adjusting for growth, MASS's PEG of -0.73 indicates potential undervaluation.

-0.73

Price to Book

The market values 908 Devices Inc. at 1.72 times its book value. This may indicate undervaluation.

1.72

EV/EBITDA

Enterprise value stands at -7.83 times EBITDA. This is generally considered low.

-7.83

How Well Does MASS Make Money?

Net Profit Margin

For every $100 in sales, 908 Devices Inc. keeps $-7.17 as profit after all expenses.

-7.17%

Operating Margin

Core operations generate -1.09 in profit for every $100 in revenue, before interest and taxes.

-1.09%

ROE

Management delivers $-2.96 in profit for every $100 of shareholder equity.

-2.96%

ROA

908 Devices Inc. generates $-2.16 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.16%

Following the Money - Real Cash Generation

Operating Cash Flow

908 Devices Inc. generates limited operating cash flow of $-27.32M, signaling weaker underlying cash strength.

$-27.32M

Free Cash Flow

908 Devices Inc. generates weak or negative free cash flow of $-28.47M, restricting financial flexibility.

$-28.47M

FCF Per Share

Each share generates $-0.79 in free cash annually.

$-0.79

FCF Yield

MASS converts -12.07% of its market value into free cash.

-12.07%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-56.72

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.73

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.49

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

-0.42

vs 25 benchmark

How MASS Stacks Against Its Sector Peers

MetricMASS ValueSector AveragePerformance
P/E Ratio-56.7229.28 Better (Cheaper)
ROE-2.96%820.00% Weak
Net Margin-7.17%-19743.00% (disorted) Weak
Debt/Equity0.030.26 Strong (Low Leverage)
Current Ratio3.494.69 Strong Liquidity
ROA-2.16%-17807.00% (disorted) Weak

MASS outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 908 Devices Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-26.67%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-4.96%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

39.25%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ